Blood Testing Market Introduction and Overview
According to SPER Market Research, the Global Blood Testing Market is estimated to reach USD 231.27 billion by 2034 with a CAGR of 9.09%.
The report includes an in-depth analysis of the Global Blood Testing Market, including market size and trends, product mix, Applications, and supplier analysis. The global blood testing market size was estimated at USD 96.89 billion in 2024 and is expected to grow at a CAGR of 9.09% from 2025 to 2034. This growth is due to increased awareness of preventative healthcare and advancements in testing technologies, supported by higher healthcare spending from governments and agencies promoting routine diagnostic testing to enhance patient outcomes. The development of advanced blood tests for early illness detection, such as COVID-19, reflects the focus on early detection and personalized care. Additionally, improved healthcare infrastructure in emerging markets is expected to support market growth during the forecast period.
By Test Type Insights: The glucose testing segment had the highest revenue share in 2024 and is expected to grow the fastest in the coming years. This growth is mainly due to greater global awareness of diabetes and its increasing prevalence, which is a major public health issue. As more people are diagnosed with diabetes, there is a higher need for solutions to monitor glucose levels and manage the disease. The shift towards home-based and point-of-care testing is also boosting glucose testing, as patients favor convenient options like blood glucose test strips, glucose meters, and wearable devices for continuous monitoring.
Regional Insights: North America blood testing market had the largest revenue share in 2024. This growth is driven by the rising number of chronic diseases, advancements in diagnostic technologies, and increased healthcare awareness. Innovations in blood testing devices and procedures, such as continuous glucose monitoring (CGM), point-of-care testing, and molecular diagnostics, have transformed disease detection and management. Companies like Abbott and Roche are leading with advanced solutions that improve test accuracy and reduce turnaround times, allowing for quicker and more informed decisions in patient care.
Market Competitive Landscape:
The blood testing industry is led by major companies that focus on improving diagnostic accuracy and accessibility. Key players like Abbott, Roche Diagnostics, and Quest Diagnostics use advanced technologies such as point-of-care devices and automated analyzers. Newer companies like Guardant Health and Bio-Rad Laboratories are also emerging with innovative solutions like liquid biopsy tests. These companies invest in research, partnerships, and regulatory approvals to meet the rising demand for early disease detection and personalized healthcare worldwide.
Recent Developments:
- In July 2024, Guardant Health, Inc. announced that the U. S. Food and Drug Administration (FDA) approved its Shield blood test for colorectal cancer (CRC) screening in adults aged 45 and older at average risk. Shield is the first FDA-approved blood test as a primary screening option for CRC.
- In April 2024, Abbott's i-STAT TBI cartridge got FDA approval for whole blood use, allowing doctors to evaluate suspected concussion patients at the bedside. It delivers lab-quality results in 15 minutes, removing the need for lab-sent plasma or serum samples.
- April 2024: BD (Becton, Dickinson, and Company) launched its BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This new set uses BD RightGauge technology for a finer needle. It also includes BD's PentaPoint Technology.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Test Type. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, bioMerieux, Quest Diagnostics Incorporated, Biomerica, BD, Siemens Healthineers AG, Danaher Corporation, Trinity Biotech Plc. |
Key Topics Covered in the Report:
- Global Blood Testing Market Size (FY’2021-FY’2034)
- Overview of Global Blood Testing Market
- Segmentation of Global Blood Testing Market By Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone, Serum Nicotine/Cotinine, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests)
- Statistical Snap of Global Blood Testing Market
- Expansion Analysis of Global Blood Testing Market
- Problems and Obstacles in Global Blood Testing Market
- Competitive Landscape in the Global Blood Testing Market
- Details on Current Investment in Global Blood Testing Market
- Competitive Analysis of Global Blood Testing Market
- Prominent Players in the Global Blood Testing Market
- SWOT Analysis of Global Blood Testing Market
- Globa Blood Testing Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Blood Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Blood Testing Market
7. Global Blood Testing Market, By Test Type (USD Million) 2021-2034
7.1. Glucose Testing
7.2. A1C Testing
7.3. Direct LDL Testing
7.4. Lipid Panel Testing
7.5. Prostate-specific Antigen Testing
7.6. COVID-19 Testing
7.7. BUN Testing
7.8. Vitamin-D Testing
7.9. Thyroid-stimulating Hormone (TSH)
7.10. Serum Nicotine/Cotinine
7.11. High sensitivity CRP Testing
7.12. Testosterone Testing
7.13. ALT Testing
7.14. Cortisol Testing
7.15. Creatinine Testing
7.16. AST Testing
7.17. Others Blood Tests
8. Global Blood Testing Market, (USD Million) 2021-2034
8.1. Global Blood Testing Market Size and Market Share
9. Global Blood Testing Market, By Region, (USD Million) 2021-2034
9.1. Asia-Pacific
9.1.1. Australia
9.1.2. China
9.1.3. India
9.1.4. Japan
9.1.5. South Korea
9.1.6. Rest of Asia-Pacific
9.2. Europe
9.2.1. France
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. United Kingdom
9.2.6. Rest of Europe
9.3. Middle East and Africa
9.3.1. Kingdom of Saudi Arabia
9.3.2. United Arab Emirates
9.3.3. Qatar
9.3.4. South Africa
9.3.5. Egypt
9.3.6. Morocco
9.3.7. Nigeria
9.3.8. Rest of Middle-East and Africa
9.4. North America
9.4.1. Canada
9.4.2. Mexico
9.4.3. United States
9.5. Latin America
9.5.1. Argentina
9.5.2. Brazil
9.5.3. Rest of Latin America
10. Company Profile
10.1. Abbott
10.1.1. Company details
10.1.2. Financial outlook
10.1.3. Product summary
10.1.4. Recent developments
10.2. F. Hoffmann-La Roche Ltd
10.2.1. Company details
10.2.2. Financial outlook
10.2.3. Product summary
10.2.4. Recent developments
10.3. Bio-Rad Laboratories, Inc
10.3.1. Company details
10.3.2. Financial outlook
10.3.3. Product summary
10.3.4. Recent developments
10.4. bioMerieux
10.4.1. Company details
10.4.2. Financial outlook
10.4.3. Product summary
10.4.4. Recent developments
10.5. Quest Diagnostics Incorporated
10.5.1. Company details
10.5.2. Financial outlook
10.5.3. Product summary
10.5.4. Recent developments
10.6. Biomerica
10.6.1. Company details
10.6.2. Financial outlook
10.6.3. Product summary
10.6.4. Recent developments
10.7. BD
10.7.1. Company details
10.7.2. Financial outlook
10.7.3. Product summary
10.7.4. Recent developments
10.8. Siemens Healthineers AG
10.8.1. Company details
10.8.2. Financial outlook
10.8.3. Product summary
10.8.4. Recent developments
10.9. Danaher Corporation
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. Trinity Biotech Plc
10.10.1. Company details
10.10.2. Financial outlook
10.10.3. Product summary
10.10.4. Recent developments
10.11. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
